Hypersensitivity 1 and 2 Flashcards
Hypersensitivity:
An exaggerated response resulting i harm to the host.
Type I hypersensitivity results in:
Release of mediators from IgE-sensitized mast cells.
Components of Type I hypersensitivity immediate reaction (5):
- Allergen specific IgE.
- Mast cells.
- Allergen.
- Eosinophils.
- CD4+ Th2 cells
Type I hypersensitivity late-phase:
Develops more slowly, characterized by the accumulation of neutrophils, eosinophils and macrophages.
Type I hypersensitivity - sensitization (4):
- First exposure to allergen.
- Antigen activation of Th2 cells and stimulation of IgE class switching in B cells (IL-4).
- Production of IgE.
- Binding of IgE to FC receptors on mast cells.
Mediators of the Type I hypersensitivity immediate reaction:
- Vasoactive amines (histamine).
- Lipid mediators.
Mediators of the Type I hypersensitivity late-phase reaction:
Cytokines.
Biologic effects of histamines (2):
- Vasodilation.
2. Vascular leak.
Biologic effects of lipid mediators (2):
- Broncho-constriction.
2. Intestinal hypermotility.
Biologic effects of cytokines:
Inflammation.
Biologic effects of enzymes:
Tissue damage.
Type I hypersensitivity late phase reaction(3):
- IL-5 from mast cells and Th2 cells recruit and activate eosinophils.
- Eosinophils release additional mediators.
- Begins within 4-8 hours and lasts 1-2 days.
Disease states caused or affected by Type I hypersensitivity (6):
- Allergic rhinitis.
- Allergic asthma.
- Eczema or atopic dermatitis.
- Some food allergy.
- Some drug allergy.
- Insect venom allergy.
Allergic march:
Progression of allergic symptoms with age.
Allergen-specific serum IgE test:
- Plate (solid phase) coated with allergen.
- Patient’s serum added.
- Labeled anti-IgE added.